$2.24T
Total marketcap
$73.66B
Total volume
BTC 56.28%     ETH 9.01%
Dominance
us

Craneware CRWRF Stock

$26.30   8.677679%
Add to favorites
Market Cap
$900.44M
LOW - HIGH [24H]
$26.30 - $26.85
VOLUME [24H]
$1.10K
P/E Ratio
41.74
Earnings per share
$0.63
ISIN
GB00B2425G68
Price   Prediction

Craneware Price Chart

Sorry, that's all we've gotfor now...

Craneware CRWRF Financial and Trading Overview

Craneware stock price 26.3 USD
Previous Close 24.2 USD
Open 26.85 USD
Bid 17.73 USD x 10000
Ask 22.73 USD x 10000
Day's Range 26.3 - 26.85 USD
52 Week Range 24.2 - 34 USD
Volume 1.1K USD
Avg. Volume 0 USD
Market Cap 900.44M USD
Beta (5Y Monthly) -0.141
PE Ratio (TTM) 41.746033
EPS (TTM) 0.63 USD
Forward Dividend & Yield 0.45 (1.85%)
Ex-Dividend Date March 19, 2026
1y Target Est N/A

CRWRF Valuation Measures

Enterprise Value 834.99M USD
Trailing P/E 41.746033
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 4.2607293
Price/Book (mrq) 2.718908
Enterprise Value/Revenue 3.951
Enterprise Value/EBITDA 27.813

Trading Information

Craneware Stock Price History

Beta (5Y Monthly) -0.141
52-Week Change -10.23%
S&P500 52-Week Change 24.48%
52 Week High 34 USD
52 Week Low 24.2 USD
50-Day Moving Average 24.2 USD
200-Day Moving Average 27.03 USD

CRWRF Share Statistics

Avg. Volume (3 month) 0 USD
Avg. Daily Volume (10-Days) 0 USD
Shares Outstanding 34.24M
Float 25.09M
Short Ratio N/A
% Held by Insiders 21.64%
% Held by Institutions 65.55%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0.389
Trailing Annual Dividend Yield 1.60%
5 Year Average Dividend Yield N/A
Payout Ratio 0.6671
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends June 30, 2025
Most Recent Quarter (mrq) December 31, 2025
Next Fiscal Year End June 30, 2026

Profitability

Profit Margin 10.63%
Operating Margin (ttm) 12.59%
Gross Margin 86.14%
EBITDA Margin 14.20%

Management Effectiveness

Return on Assets (ttm) 3.17%
Return on Equity (ttm) 6.72%

Income Statement

Revenue (ttm) 211.33M USD
Revenue Per Share (ttm) 6.03 USD
Quarterly Revenue Growth (yoy) 5.70%
Gross Profit (ttm) 182.06M USD
EBITDA 30.02M USD
Net Income Avi to Common (ttm) 22.48M USD
Diluted EPS (ttm) 0.63
Quarterly Earnings Growth (yoy) 38.89%

Balance Sheet

Total Cash (mrq) 40.95M USD
Total Cash Per Share (mrq) 1.17 USD
Total Debt (mrq) 26.9M USD
Total Debt/Equity (mrq) 7.93 USD
Current Ratio (mrq) 0.773
Book Value Per Share (mrq) 9.673

Cash Flow Statement

Operating Cash Flow (ttm) 10.24M USD
Levered Free Cash Flow (ttm) -3549000 USD

Profile of Craneware

Country United States
State N/A
City Edinburgh
Address 1 Tanfield
ZIP EH3 5DA
Phone 44 13 1550 3100
Website https://www.thecranewaregroup.com
Industry Health Information Services
Sector(s) Healthcare
Full Time Employees 765

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. It provides solutions, such as Trisus Pricing Analyzer and Transparency, a solution that optimizes and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity requirements; Trisus Claims Informatics, a retrospective charge capture analytical application; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit solution for government and commercial payors. The company also offers Trisus Decision Support; Trisus Labor Productivity, which enables healthcare providers to manage, analyze, and plan the deployment of workforce; Trisus Medication Analytic solutions that prioritize, diagnose, and resolve issues in medication systems; and Trisus Supplies Assistant solutions which supplies charged data. In addition, it provides Sentrex, a SaaS-based solution that helps covered entities expand medication access; Sentinel, that tracks all drug activity; Referral Verification System; and Central Pharmacy Distribution, a centralized purchasing application. Further, the company offers professional, pharmacy professional, and appeal services. Additionally, the company provides The Academy, an interactive learning center for user training; Trisus Pricing Integrity Suite; Trisus Business of Pharmacy Suite, which offers solutions centered on each link in the medication revenue cycle; Trisus Value-based Margin and Productivity Suite; and Trisus Data Integrity Suite, which creates a proactive workflow that aligns data between operating units, the supply chain and revenue cycle. Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.

Q&A For Craneware Stock

What is a current CRWRF stock price?

Craneware CRWRF stock price today per share is 26.3 USD.

How to purchase Craneware stock?

You can buy CRWRF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Craneware?

The stock symbol or ticker of Craneware is CRWRF.

Which industry does the Craneware company belong to?

The Craneware industry is Health Information Services.

How many shares does Craneware have in circulation?

The max supply of Craneware shares is 34.24M.

What is Craneware Price to Earnings Ratio (PE Ratio)?

Craneware PE Ratio is 41.74603300 now.

What was Craneware earnings per share over the trailing 12 months (TTM)?

Craneware EPS is 0.63 USD over the trailing 12 months.

Which sector does the Craneware company belong to?

The Craneware sector is Healthcare.

Select currency